Regional Growth Immunostics' presence at Medlab Middle East 2023 indicates readiness to expand distribution and partnerships in the Middle East and other emerging markets for oncology, women's health, and infectious disease diagnostics. Target distributor agreements, local regulatory support, and hospital networks to accelerate adoption of AFIAS platforms and new assays.

Portfolio Synergy A diversified focus across oncology, women's health, infectious disease, respiratory, and toxicology creates cross selling opportunities with labs and hospitals. Consider bundling AFIAS analyzers with additional assays to streamline workflows and improve diagnostic turnaround.

Channel Partnerships The small scale and past acquisition activity suggest a need for strong channel partnerships. Explore OEM, licensing, and distribution deals with mid-size to large players to broaden reach in hospitals, clinics, and corporate health programs.

Workforce Health Past collaboration with Mountain Country Foods to support workforce health during COVID-19 signals potential for ongoing occupational health offerings. Target employers, insurers, and healthcare providers serving corporate wellness with screening, monitoring, and related services.

Digital Growth A mixed digital stack including Wix, WordPress, and eCommerce presents opportunities to optimize online sales for labs, enhance digital marketing, and integrate with CRM and ERP systems for streamlined lead capture, order fulfillment, and service contracts.